A practical guide to achieving and maintaining the best response to lenalidomide in multiple myeloma: roundtable proceedings

Clin Adv Hematol Oncol. 2007 Oct;5(10 Suppl 15):7-19, quiz 21-2.
No abstract available

Publication types

  • Consensus Development Conference

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Lenalidomide
  • Multiple Myeloma / drug therapy*
  • Thalidomide / adverse effects
  • Thalidomide / analogs & derivatives*
  • Thalidomide / therapeutic use

Substances

  • Antineoplastic Agents
  • Thalidomide
  • Lenalidomide